Saba/Weinstein Sells 81,045 ECAT Shares at ~$16.6
Form 4 summary: Saba Capital Management, L.P. and Boaz Weinstein reported insider sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock.
Rhea-AI Filing Summary
Form 4 summary: Saba Capital Management, L.P. and Boaz Weinstein reported insider sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock. On 08/28/2025 they sold 4,397 shares at $16.63 and on 08/29/2025 they sold 76,648 shares at $16.51. Beneficial ownership declined from 28,600,644 shares to 28,523,996 shares; ownership is reported indirect. The filing is signed by Saba and Boaz Weinstein.
Positive
- None.
Negative
- None.
Insights
TL;DR: Reported insider sales totaling 81,045 shares reduced indirect holdings slightly; impact appears routine and not materially transformative.
The two sales on 08/28/2025 and 08/29/2025 total 81,045 common shares sold at average prices near $16.6, lowering reported indirect beneficial ownership from 28,600,644 to 28,523,996 shares. The absolute size of remaining holdings remains large, and the transactions are reported as routine dispositions rather than derivative exercises or acquisitions. From a financial-analysis perspective, these transactions do not by themselves indicate a material change to the company’s capital structure or a shift in control.
TL;DR: Insider sales were disclosed properly on Form 4; filings show indirect ownership and include required signatures.
The Form 4 identifies Saba Capital Management, L.P. and Boaz Weinstein as reporting persons and marks the relationship as director and 10% owner. Transactions are coded as sales with prices and post-transaction beneficial ownership reported. The document includes signatures and dates, meeting disclosure formalities. There is no indication in the filing of an affiliated plan or unusual timing that would raise governance flags from the filing alone.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 76,648 | $16.51 | $1.27M |
| Sale | Common Stock | 4,397 | $16.63 | $73K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions were reported for ECAT?
Who filed the Form 4 for ECAT?
How did beneficial ownership change after the reported transactions?
Were the transactions purchases or sales?
Are there derivative transactions reported in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.